Urinary tract infections vaccine - Xanodyne

Drug Profile

Urinary tract infections vaccine - Xanodyne

Alternative Names: UTI vaccine - Xanodyne

Latest Information Update: 24 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Xanodyne Pharmaceuticals
  • Class Vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Urinary tract infections

Most Recent Events

  • 24 Aug 2015 Discontinued - Phase-II for Urinary tract infections in USA (Transmucosal)
  • 15 Dec 2004 Phase-II clinical trials in Urinary tract infections in USA (Transmucosal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top